Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://georgiakwxs335977.howeweb.com/39666974/trelaglutide-exploring-a-new-option-for-chronic-diseases